RANI KUMARAN

Allopathic & Osteopathic Physicians|Internal Medicine|Pulmonary Disease CUMMING, GA NPI 1467616144

General Payments — all program years on this page

$3,562.30

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 77
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $291.59 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $291.5915

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,277.326
2019 $856.6413
2020 $344.609
2021 $227.828
2022 $298.0912
2023 $266.2414
2024 $291.5915

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078882851 Actelion Pharmaceuticals US, Inc. $15.13 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078882889 Actelion Pharmaceuticals US, Inc. $14.98 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078882891 Actelion Pharmaceuticals US, Inc. $13.90 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104589734 AstraZeneca Pharmaceuticals LP $22.61 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104762646 AstraZeneca Pharmaceuticals LP $27.25 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105455055 AstraZeneca Pharmaceuticals LP $13.75 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115776070 GlaxoSmithKline, LLC. $20.46 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116562284 GlaxoSmithKline, LLC. $23.62 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116695183 GlaxoSmithKline, LLC. $22.70 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124740670 Grifols USA, LLC $14.88 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124740672 Grifols USA, LLC $20.59 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137609842 Takeda Pharmaceuticals U.S.A., Inc. $20.07 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139650773 GENZYME CORPORATION $14.48 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147310845 Mylan Specialty L.P. $20.44 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147375436 Mylan Specialty L.P. $26.73 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.